Attending CRO Summit next month in Raleigh (or live/work in the area)? Join us for some cocktails and conversation on December 2nd. We're excited to be co-hosting next month's Triangle Bio Connections event with our good friends TSTrials and Block Clinical Inc. RSVP Below. https://lnkd.in/eXBR95_C
关于我们
When our founder Bryan Manning discovered a clinical trial that could have cured his retinal eye disease failed because it could not find enough patients, he was devastated. He then made it his mission to never allow a trial to fail, because it could not find the patients the treatment could benefit the most. He turned his world-class team from Two Blind Brothers, the fastest-growing cause-driven company in the country, to change the landscape of clinical trial recruitment by leveraging the greatest patient outreach tool ever created, social platforms. Clinical Enrollment treats every clinical trial as a unique startup; crafting your novel story, developing content to reflect your values, and using the most sophisticated multi-platform targeting to find the perfect patients for your trial. Because we believe you are changing the future of medicine, and we want to be a part of your extraordinary story. We find candidates by using the most sophisticated social media ad buying learned in the most competitive industries in the world, and connect that patient's experience to your efforts by telling authentic, emotional, and informative stories, then seamlessly qualify them by being a trusted partner.
- 网站
-
clinicalenrollment.com
Clinical Enrollment的外部链接
- 所属行业
- 生物技术研究
- 规模
- 2-10 人
- 总部
- Charlottesville，Virginia
- 类型
- 私人持股
- 创立
- 2022
地点
-
主要
获取路线
US，Virginia，Charlottesville
Clinical Enrollment员工
-
Jeff Eggeling
Head of Partnerships & Sponsor Relations @ Clinical Enrollment
-
Bryan Manning
Forbes 30u30 | Founder of Clinical Enrollment + Co-Founder of Two Blind Brother l Facebook Small Business Councial
-
Glenna Allison Dupree
Open to Work!
-
Andrew Jamison
Partnership Associate, Co-President of SMIF at University of Lynchburg
动态
-
20/20 Onsite is proud to partner with Sano Genetics and Clinical Enrollment to advance care and clinical research for patients with inherited retinal diseases (IRDs). This collaboration simplifies access to genetic testing, personalized support, and clinical trials. 20/20 Onsite will provide onsite patient screenings through Mobile Vision Clinics. Sano Genetics will offer genetic testing, counseling, and a virtual patient education platform. Clinical Enrollment will manage patient recruitment, medical record retrieval, and logistics. Combining our strengths reduces barriers to care, especially for underserved communities, and accelerates clinical research timelines to bring vision-saving treatments to more patients. Learn how this partnership is expanding patient access to specialized care and research: https://hubs.ly/Q02VFd100 #ClinicalResearch #Ophthalmology #InheritedRetinalDisease #GeneticTesting #PatientCare
-
-
This past Friday, we announced a joint partnership with 20/20 Onsite and Clinical Enrollment to help solve for many of the challenges in finding the right participants for Inherited Retinal Disease (IRD) trials. You can read more about the partnership here: https://lnkd.in/e9m5yFsh I am beyond grateful to be working with incredible colleagues, including Sonali Bloom, Jessica McKenzie Mays, Katie Sigg, COT, OSA, OSC, Bryan Manning, and Jeff Eggeling on this collaboration. Never have I encountered a group of people who are so committed to doing the hard work of figuring out how to integrate multiple systems and business models in a short period of time to make things just a little easier for individuals and families that are looking for treatment options. If you are interested in learning more, please reach out! We would love to talk to you about what we are doing.
-
-
Forbes 30u30 | Founder of Clinical Enrollment + Co-Founder of Two Blind Brother l Facebook Small Business Councial
What am I most thrilled about at #AAO2024? If you are in Chicago, I would be thrilled to say hello.
-
Attending American Academy of Ophthalmology conference in Chicago this week? Want to have a cocktail and hear about the most exciting partnership in IRD Clinical Research? Join Clinical Enrollment 20/20 Onsite and Sano Genetics this Friday. Space is limited, contact Jeff Eggeling [email protected] about attending. Can't make it but want to learn more? Send us a message!
-
-
Forbes 30u30 | Founder of Clinical Enrollment + Co-Founder of Two Blind Brother l Facebook Small Business Councial
The #NobelPrize in #Chemistry was just announced, and it will change drug development forever. Using?#AI,?we can now model what a protein structure will look like, meaning we can test structures that do not appear in nature to help us find treatments, preventions and cures in the future in months rather than years.
-
Forbes 30u30 | Founder of Clinical Enrollment + Co-Founder of Two Blind Brother l Facebook Small Business Councial
1.3 million Type 1 Diabetic patients in the US may have a future without external insulin. The VX-880?# clinical trial?published data showing that 7 out of 10 participants were no longer using exogenous insulin at the 180-day mark with no hyperglycemic events. If you want to participate, link:https://lnkd.in/e-8NkJYt American Diabetic Association article: https://lnkd.in/eKYKazWh. Felicia Pagliuca Vertex Pharmaceuticals
-
Forbes 30u30 | Founder of Clinical Enrollment + Co-Founder of Two Blind Brother l Facebook Small Business Councial
Access to #clinicaltrials may have just changed forever. Walmart and Walgreens Healthcare Solutions have both created programs in partnership with Eli Lilly and Company and Pfizer respectively to bring clinical trials to more communities through in-store access. At Clinical Enrollment, we strive every day to expand awareness and access to trials through digital efforts, but to see it being pursued on such a large scale is amazing. Thank you, Ramita Tandon and Rob Goodwin, for a great article. https://lnkd.in/e6pnHPTi